Lower phenytoin serum levels in persons switched from brand to generic phenytoin
- 26 October 2004
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Neurology
- Vol. 63 (8), 1494-1496
- https://doi.org/10.1212/01.wnl.0000142091.47698.a2
Abstract
After generic phenytoin (PHT) was marketed, the authors identified eight adult patients (ages 34 to 49) whose seizures increased enough to require intervention after switching to generic PHT. The mean total PHT concentration on brand (before generic) was 17.7 ± 5.3 mg/L, decreased to 12.5 ± 2.7 mg/L with generic, and increased to 17.8 ± 3.9 mg/L after brand was re-introduced. Brand and generic PHT do not yield equivalent concentrations in some patients and substitution should not be permitted without physician notification.Keywords
This publication has 6 references indexed in Scilit:
- Effect of food on absorption of Dilantin Kapseals and Mylan extended phenytoin sodium capsulesNeurology, 2001
- Bioavailability and dissolution of proprietary and generic formulations of phenytoin.Journal of Neurology, Neurosurgery & Psychiatry, 1992
- Generic substitutions for antiepileptic drugsNeurology, 1990
- Review of Alterations in Oral Phenytoin Bioavailability Associated with Formulation, Antacids, and FoodTherapeutic Drug Monitoring, 1986
- Effect of Antacids on Phenytoin BioavailabilityTherapeutic Drug Monitoring, 1981
- Bioavailability of 11 phenytoin productsJournal of Pharmacokinetics and Biopharmaceutics, 1977